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The presence of plasmid-mediated quinolone resistance genes [i.e., qnrA, qnrB, qnrS, aac(6)-Ib-cr, and qepA]
was evaluated among 42 blaKPC-containing Klebsiella pneumoniae isolates collected in the eastern United States.
One isolate carried the blaKPC-3 and qnrB19 genes on the same conjugative plasmid, whereas another carried
the blaKPC-3 and qnrA1 genes on separate plasmids.
The rapid spread of Klebsiella pneumoniae carbapenemases
(KPCs) among members of the family Enterobacteriaceae rep-
resents an escalating global threat (15). Since blaKPC genes
confer resistance to all -lactams, the only therapeutic options
for treating infections due to organisms possessing these -lac-
tamases are quinolones, aminoglycosides, polymyxins, or com-
binations of agents for which there are few data on efficacy
(15). Unfortunately, high-level resistance to ciprofloxacin, gen-
tamicin, and amikacin is also frequently observed among
blaKPC-containing K. pneumoniae isolates (2, 3).
Quinolone resistance among Enterobacteriaceae is usually
mediated by chromosomal mutations in the genes encoding
DNA gyrase and topoisomerase IV. Plasmid-mediated quino-
lone resistance (PMQR) can arise from the expression of pro-
teins encoded by the qnrA, -B, and -S genes that are able to
protect the DNA gyrase. In addition, an aminoglycoside acetyl-
transferase encoded by the aac(6)-Ib-cr gene also confers cip-
rofloxacin resistance (10, 12). The qnr and aac(6)-Ib-cr loci are
frequently found among Enterobacteriaceae producing AmpC
enzymes, extended-spectrum -lactamases, or both (1, 7, 8,
13). A plasmid-mediated quinolone efflux pump (i.e., the qepA
gene) also has been described in Escherichia coli (17).
Recently, Mendes et al. reported the detection of a single K.
pneumoniae isolate in China possessing blaKPC-2 and qnrB4 on
the same conjugative plasmid (6). However, the prevalence of
PMQR determinants among K. pneumoniae isolates producing
KPCs has not yet been examined. Therefore, we studied a set
of K. pneumoniae isolates collected at five major health care
institutions located in the eastern United States to estimate the
frequency of PMQR among KPC producers.
Eighty-five nonreplicated K. pneumoniae clinical isolates
showing reduced susceptibility (i.e., MIC, 0.5 mg/liter) to
imipenem, meropenem, or ertapenem were studied by using
PCR amplification and DNA sequencing to detect the pres-
ence of the blaKPC genes and to confirm their identity (forward
primer, 5-ATGTCACTGTATCGCCGTC-3; reverse primer,
5-TTACTGCCCGTTGACGCC-3). The isolates were ran-
domly collected from January 2006 to October 2007 from
Mount Sinai Medical Center in New York (MSMC), the Uni-
versity of Pittsburgh Medical Center (UPMC), and three
Cleveland institutions, including the University Hospital Case
Medical Center (UHCMC), the Cleveland Clinic Foundation
(CCF), and the Louis Stokes Cleveland Department of Veter-
ans Affairs Medical Center (LSVAMC).
Overall, 42 K. pneumoniae clinical isolates possessed a
blaKPC gene (MSMC, n  24; UPMC, n  4; UHCMC, n  2;
CCF, n  9; LSVAMC, n  3). In particular, 25 isolates
amplified blaKPC-2, and the remaining 17 amplified blaKPC-3.
PCR and DNA sequence analysis of the PMQR determinants,
the blaTEM, blaSHV, and blaCTX-M genes, were performed as
previously reported (5, 7, 13, 14, 16). Two of the 42 (4.8%) K.
pneumoniae isolates containing blaKPC also encoded a PMQR
determinant. For these two isolates, conjugation experiments
were performed using E. coli J53 (rifampin resistant) as the
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recipient strain. After overnight incubation, transconjugants
were selected by plating the conjugation mixture (donor and
recipient strains) onto MacConkey agar supplemented with
ceftazidime (10 mg/liter) and rifampin (100 mg/liter) (11). An-
timicrobial susceptibility testing results for the two donors
and their E. coli J53 transconjugants are shown in Table 1.
Both K. pneumoniae isolates demonstrated increased MICs
for carbapenems. In contrast, only one strain (VA367) ex-
pressed high-level resistance to quinolones, whereas the
other (VA375) showed only a small increase in the MICs.
K. pneumoniae VA367 was isolated in November 2007 from
a sputum sample from a 75-year-old man admitted to the
surgery service of the LSVAMC with a diagnosis of adenocar-
cinoma of the esophagus. He had not received antibiotics in
the preceding 12 months. On the first hospital day, the patient
underwent a transhiatal esophagectomy and received pip-
eracillin-tazobactam (3.375 g every 6 h) perioperatively for
36 h. Since fever and leukocytosis developed on the fifth post-
operative day, administration of piperacillin-tazobactam was
resumed. On the 11th postoperative day, the patient suffered
cardiorespiratory arrest. He was intubated and transferred to
the intensive care unit. Fever persisted, and on the 16th post-
operative day, a sputum culture grew Enterobacter aerogenes,
which had intermediate resistance to ceftazidime but was sus-
ceptible to piperacillin-tazobactam and carbapenems, and K.
pneumoniae VA367 as a coisolate (Table 1). On the 22nd
postoperative day, therapy was changed to meropenem (500
mg every 8 h). Fever persisted, and on the 27th postoperative
day, tigecycline therapy (100 mg followed by 50 mg every 12 h)
was initiated. The patient died on the 28th day after hospital
admission.
Molecular analysis of K. pneumoniae VA367 revealed the
following resistance determinants: blaKPC-3, qnrB19, blaTEM-1,
blaSHV-11, blaSHV-12, and aac(6)-Ib. The E. coli transconjugant
of strain VA367 contained the blaKPC-3, qnrB19, blaTEM-1,
blaSHV-11, and aac(6)-Ib genes. Analytical isoelectric focusing
(aIEF) was performed as previously described (9). aIEF re-
vealed that the donor and transconjugant strains possessed
-lactamases at pIs of 5.4, 6.7, and 7.6; only the donor had an
additional -lactamase at pI 8.2. Strain VA367 and its
transconjugant carried one transferable plasmid of approxi-
mately 80 kb.
K. pneumoniae VA375 was recovered on August 2007 from
a culture of a blood sample obtained from a 58-year-old man
admitted to the UHCMC for a kidney transplant. He received
intravenous ciprofloxacin (400 mg/day) and amikacin (500 mg
after each hemodialysis) treatment for 14 days, with complete
resolution of the infection. Molecular analysis demonstrated
that the isolate contained blaKPC-3, qnrA1, blaTEM-1, and
blaSHV-11. The qnrA1, blaTEM-1, and blaSHV-11 genes were
transferred to E. coli J53, whereas blaKPC-3 was not. aIEF
showed -lactamases at pIs of 5.4, 5.8, 6.7, 7.0, and 7.6 in the
TABLE 1. Susceptibility test results of the parental K. pneumoniae isolates, VA367 and VA375, and the corresponding E. coli J53
transconjugants, VA367-J53 and VA375-J53a
Antimicrobial drug
VA367
blaKPC-3 qnrB19
blaTEM-1 blaSHV-11
blaSHV-12 aac(6)-Ib
VA367-J53
blaKPC-3 qnrB19
blaTEM-1
blaSHV-11 aac(6)-Ib
VA375
(blaKPC-3
qnrA1 blaTEM-1
blaSHV-11)
VA375-J53
(qnrA1 blaTEM-1 blaSHV-11)
E. coli J53
MIC
(g/ml)
Suscepti-
bilityc
MIC
(g/ml)
Suscepti-
bility
MIC
(g/ml)
Suscepti-
bility
MIC
(g/ml)
Suscepti-
bility
MIC
(g/ml)
Suscepti-
bility
Levofloxacin 8 (32) R 1 (0.75) S 1 (0.75) S 1 (1.5) S 0.25 (0.25) S
Ciprofloxacin 4 (32) R 1 (1) S 1 (0.75) S 1 (2) S 0.25 (0.25) S
Gentamicin 4 S 1 S 16 R 4 S 1 S
Amikacin 64 R 16 S 2 S 2 S 2 S
Tobramycin 16 R 16 R 16 R 4 S 1 S
Trimethoprim-
sulfamethoxazole
320 R 20 S 320 R 320 R 20 S
Nitrofurantoin 512 R 16 S 64 I 16 S 16 S
Tigecyclineb (3) (0.5) (1.5) (0.5) (0.5)
Colistinb (1.5) (0.38) (1) (0.38) (0.38)
Piperacillin 128 R 128 R 128 R 128 R 4 S
Piperacillin-
tazobactam
128 R 64 I 128 R 64 I 4 S
Ampicillin-
sulbactam
32 R 32 R 32 R 32 R 4 S
Cefazolin 64 R 64 R 64 R 64 R 4 S
Cefuroxime 64 R 64 R 64 R 64 R 16 I
Ceftazidime 64 R 32 R 64 R 64 R 1 S
Ceftriaxone 64 R 8 S 32 I 8 S 1 S
Cefepime 64 R 2 S 64 R 1 S 1 S
Aztreonam 64 R 64 R 64 R 2 S 1 S
Meropenem 2 (8) S (I) 1 (4) S (S) 1 (4) S (S) 0.25 (0.38) S 0.25 (0.047) S
Imipenem 2 (16) S (R) 4 (4) S (S) 2 (8) S (I) 1 (0.38) S 1 (0.25) S
Ertapenem (16) (R) (2) (S) (8) (I) (0.125) (S) (0.023) (S)
a The antimicrobial susceptibility tests were performed with the Vitek 2 system, using AST-GN09 cards (bioMe´rieux, Durham, NC). The results were interpreted
according to the Clinical and Laboratory Standards Institute (CLSI; formerly NCCLS) criteria (4). All MIC and susceptibility data given in parentheses were obtained
by the Etest method (AB Biodisk, Solna, Sweden) on Mueller-Hinton agar.
b Interpretative criteria for this drug have not yet been released by the CLSI (4).
c S, susceptible; I, intermediate; R, resistant.
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donor isolate, but the -lactamases at pIs of 5.4, 5.8, and 7.6
were observed only in the transconjugant strain. VA375 con-
tained at least two plasmids of approximately 80 kb and 130 kb,
whereas the transconjugant contained only the larger plasmid.
This is the first molecular epidemiological survey assessing
the spread of PMQR genes among blaKPC-containing K. pneu-
moniae isolates. Our limited survey suggests that the preva-
lence of these isolates in the United States may be approxi-
mately 5%. VA367 represents the first K. pneumoniae isolate
reported to carry both the blaKPC-3 and qnrB genes on a single
conjugative plasmid. Strain VA375 is the first observed K.
pneumoniae clinical isolate possessing both the blaKPC and
qnrA genes. In both strains, the qnr genes were cotransferred
with other important drug-resistant elements [e.g., -lactama-
ses and aminoglycoside resistance determinants, such as
aac(6)-1b]. These findings warn us that novel combinations of
transferable resistance determinants continue to emerge and
could seriously undermine therapeutic regimens with -lac-
tams, fluoroquinolones, and aminoglycosides. The possibility
of K. pneumoniae transferring these resistant plasmids to other
Enterobacteriaceae and nonfermenting gram-negative bacilli is
a serious consideration in the care of hospitalized patients.
This work was supported in part by AstraZeneca, the National
Institutes of Health (grant RO1-AI63517), and the Veterans Affairs
Merit Review Program.
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